APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Injection Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Intravenous Injection Immunoglobulin Market Outlook and Growth Opportunities 2026

31 December 2025198 pages

Choose your research edition.

Industry ResearchIntravenous Injection Immunoglobulin Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Injection Immunoglobulin Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Intravenous Injection Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Injection Immunoglobulin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Injection Immunoglobulin Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Intravenous Injection Immunoglobulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Intravenous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Intravenous Injection Immunoglobulin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Intravenous Injection Immunoglobulin market include Boya-Bio, CTBB, Sinopharm, Beijing Tiantan Biological Products, Guangdong Shuagnlin Bio-pharmacy, Hualan Bio, Nanyue Biopharming, Shanghai RAAS and Weiguang Biological, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intravenous Injection Immunoglobulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Injection Immunoglobulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Injection Immunoglobulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Injection Immunoglobulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Injection Immunoglobulin Segment by Company

Boya-Bio

CTBB

Sinopharm

Beijing Tiantan Biological Products

Guangdong Shuagnlin Bio-pharmacy

Hualan Bio

Nanyue Biopharming

Shanghai RAAS

Weiguang Biological

Intravenous Injection Immunoglobulin Segment by Type

5g/100ml

2.5g/50ml

1g/20ml

10g/200ml

1.25g/25ml

Intravenous Injection Immunoglobulin Segment by Application

Hospital

Clinic

Others

Intravenous Injection Immunoglobulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Intravenous Injection Immunoglobulin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Intravenous Injection Immunoglobulin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intravenous Injection Immunoglobulin significant trends, drivers, influence factors in global and regions.

6. To analyze Intravenous Injection Immunoglobulin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Injection Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Injection Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Injection Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Injection Immunoglobulin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intravenous Injection Immunoglobulin industry.

Chapter 3: Detailed analysis of Intravenous Injection Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Intravenous Injection Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Intravenous Injection Immunoglobulin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intravenous Injection Immunoglobulin Industry Trends Table 2. Intravenous Injection Immunoglobulin Industry Drivers Table 3. Intravenous Injection Immunoglobulin Industry Opportunities and Challenges Table 4. Intravenous Injection Immunoglobulin Industry Restraints Table 5. Global Intravenous Injection Immunoglobulin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intravenous Injection Immunoglobulin Revenue Share by Company (2021-2026) Table 7. Global Intravenous Injection Immunoglobulin Sales Volume by Company (L) & (2021-2026) Table 8. Global Intravenous Injection Immunoglobulin Sales Volume Share by Company (2021-2026) Table 9. Global Intravenous Injection Immunoglobulin Average Price (US$/ml) of Company (2021-2026) Table 10. Global Intravenous Injection Immunoglobulin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Intravenous Injection Immunoglobulin Key Company Manufacturing Base & Headquarters Table 12. Global Intravenous Injection Immunoglobulin Company, Product Type & Application Table 13. Global Intravenous Injection Immunoglobulin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Injection Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5g/100ml Table 18. Significant Companies of 2.5g/50ml Table 19. Significant Companies of 1g/20ml Table 20. Significant Companies of 10g/200ml Table 21. Significant Companies of 1.25g/25ml Table 22. Global Intravenous Injection Immunoglobulin Sales Volume by Type 2021 VS 2025 VS 2032 (L) Table 23. Global Intravenous Injection Immunoglobulin Sales Volume by Type (2021-2026) & (L) Table 24. Global Intravenous Injection Immunoglobulin Sales Volume by Type (2027-2032) & (L) Table 25. Global Intravenous Injection Immunoglobulin Sales Volume Share by Type (2021-2026) Table 26. Global Intravenous Injection Immunoglobulin Sales Volume Share by Type (2027-2032) Table 27. Global Intravenous Injection Immunoglobulin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Intravenous Injection Immunoglobulin Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Intravenous Injection Immunoglobulin Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Intravenous Injection Immunoglobulin Sales Value Share by Type (2021-2026) Table 31. Global Intravenous Injection Immunoglobulin Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Others Table 35. Global Intravenous Injection Immunoglobulin Sales Volume by Application 2021 VS 2025 VS 2032 (L) Table 36. Global Intravenous Injection Immunoglobulin Sales Volume by Application (2021-2026) & (L) Table 37. Global Intravenous Injection Immunoglobulin Sales Volume by Application (2027-2032) & (L) Table 38. Global Intravenous Injection Immunoglobulin Sales Volume Share by Application (2021-2026) Table 39. Global Intravenous Injection Immunoglobulin Sales Volume Share by Application (2027-2032) Table 40. Global Intravenous Injection Immunoglobulin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Intravenous Injection Immunoglobulin Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Intravenous Injection Immunoglobulin Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Intravenous Injection Immunoglobulin Sales Value Share by Application (2021-2026) Table 44. Global Intravenous Injection Immunoglobulin Sales Value Share by Application (2027-2032) Table 45. Global Intravenous Injection Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032 (L) Table 46. Global Intravenous Injection Immunoglobulin Sales by Region (2021-2026) & (L) Table 47. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2021-2026) Table 48. Global Intravenous Injection Immunoglobulin Sales by Region (2027-2032) & (L) Table 49. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2027-2032) Table 50. Global Intravenous Injection Immunoglobulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Intravenous Injection Immunoglobulin Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Intravenous Injection Immunoglobulin Sales Value Share by Region (2021-2026) Table 53. Global Intravenous Injection Immunoglobulin Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Intravenous Injection Immunoglobulin Sales Value Share by Region (2027-2032) Table 55. Global Intravenous Injection Immunoglobulin Market Average Price (US$/ml) by Region (2021-2026) Table 56. Global Intravenous Injection Immunoglobulin Market Average Price (US$/ml) by Region (2027-2032) Table 57. Global Intravenous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (L) Table 58. Global Intravenous Injection Immunoglobulin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Intravenous Injection Immunoglobulin Sales by Country (2021-2026) & (L) Table 60. Global Intravenous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 61. Global Intravenous Injection Immunoglobulin Sales by Country (2027-2032) & (L) Table 62. Global Intravenous Injection Immunoglobulin Sales Market Share by Country (2027-2032) Table 63. Global Intravenous Injection Immunoglobulin Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Intravenous Injection Immunoglobulin Sales Value Market Share by Country (2021-2026) Table 65. Global Intravenous Injection Immunoglobulin Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Intravenous Injection Immunoglobulin Sales Value Market Share by Country (2027-2032) Table 67. Boya-Bio Company Information Table 68. Boya-Bio Business Overview Table 69. Boya-Bio Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 70. Boya-Bio Intravenous Injection Immunoglobulin Product Portfolio Table 71. Boya-Bio Recent Development Table 72. CTBB Company Information Table 73. CTBB Business Overview Table 74. CTBB Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 75. CTBB Intravenous Injection Immunoglobulin Product Portfolio Table 76. CTBB Recent Development Table 77. Sinopharm Company Information Table 78. Sinopharm Business Overview Table 79. Sinopharm Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 80. Sinopharm Intravenous Injection Immunoglobulin Product Portfolio Table 81. Sinopharm Recent Development Table 82. Beijing Tiantan Biological Products Company Information Table 83. Beijing Tiantan Biological Products Business Overview Table 84. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 85. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Portfolio Table 86. Beijing Tiantan Biological Products Recent Development Table 87. Guangdong Shuagnlin Bio-pharmacy Company Information Table 88. Guangdong Shuagnlin Bio-pharmacy Business Overview Table 89. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 90. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Portfolio Table 91. Guangdong Shuagnlin Bio-pharmacy Recent Development Table 92. Hualan Bio Company Information Table 93. Hualan Bio Business Overview Table 94. Hualan Bio Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 95. Hualan Bio Intravenous Injection Immunoglobulin Product Portfolio Table 96. Hualan Bio Recent Development Table 97. Nanyue Biopharming Company Information Table 98. Nanyue Biopharming Business Overview Table 99. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 100. Nanyue Biopharming Intravenous Injection Immunoglobulin Product Portfolio Table 101. Nanyue Biopharming Recent Development Table 102. Shanghai RAAS Company Information Table 103. Shanghai RAAS Business Overview Table 104. Shanghai RAAS Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 105. Shanghai RAAS Intravenous Injection Immunoglobulin Product Portfolio Table 106. Shanghai RAAS Recent Development Table 107. Weiguang Biological Company Information Table 108. Weiguang Biological Business Overview Table 109. Weiguang Biological Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 110. Weiguang Biological Intravenous Injection Immunoglobulin Product Portfolio Table 111. Weiguang Biological Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Intravenous Injection Immunoglobulin Distributors List Table 115. Intravenous Injection Immunoglobulin Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Intravenous Injection Immunoglobulin Product Image Figure 2. Global Intravenous Injection Immunoglobulin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Injection Immunoglobulin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Intravenous Injection Immunoglobulin Sales (2021-2032) & (L) Figure 5. Global Intravenous Injection Immunoglobulin Sales Average Price (US$/ml) & (2021-2032) Figure 6. Global Intravenous Injection Immunoglobulin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5g/100ml Image Figure 10. 2.5g/50ml Image Figure 11. 1g/20ml Image Figure 12. 10g/200ml Image Figure 13. 1.25g/25ml Image Figure 14. Global Intravenous Injection Immunoglobulin Sales Volume by Type (2021 VS 2025 VS 2032) & (L) Figure 15. Global Intravenous Injection Immunoglobulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Intravenous Injection Immunoglobulin Sales Volume Share by Type (2021-2032) Figure 17. Global Intravenous Injection Immunoglobulin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Intravenous Injection Immunoglobulin Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Intravenous Injection Immunoglobulin Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Intravenous Injection Immunoglobulin Sales Volume by Application (2021 VS 2025 VS 2032) & (L) Figure 24. Global Intravenous Injection Immunoglobulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Intravenous Injection Immunoglobulin Sales Volume Share by Application (2021-2032) Figure 26. Global Intravenous Injection Immunoglobulin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Intravenous Injection Immunoglobulin Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Intravenous Injection Immunoglobulin Sales Value Share by Application (2021-2032) Figure 29. Global Intravenous Injection Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032 (L) Figure 30. Global Intravenous Injection Immunoglobulin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Intravenous Injection Immunoglobulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Intravenous Injection Immunoglobulin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Intravenous Injection Immunoglobulin Sales Value (2021-2032) & (US$ Million) Figure 34. North America Intravenous Injection Immunoglobulin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Intravenous Injection Immunoglobulin Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Intravenous Injection Immunoglobulin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Intravenous Injection Immunoglobulin Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Intravenous Injection Immunoglobulin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Intravenous Injection Immunoglobulin Sales Value (2021-2032) & (US$ Million) Figure 40. South America Intravenous Injection Immunoglobulin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Intravenous Injection Immunoglobulin Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Intravenous Injection Immunoglobulin Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Intravenous Injection Immunoglobulin Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Intravenous Injection Immunoglobulin Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 5g/100ml
  • 2.5g/50ml
  • 1g/20ml
  • 10g/200ml
  • 1.25g/25ml
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boya-Bio
  • CTBB
  • Sinopharm
  • Beijing Tiantan Biological Products
  • Guangdong Shuagnlin Bio-pharmacy
  • Hualan Bio
  • Nanyue Biopharming
  • Shanghai RAAS
  • Weiguang Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Injection Immunoglobulin Sales Value (2021-2032)
  4. 1.2.2 Global Intravenous Injection Immunoglobulin Sales Volume (2021-2032)
  5. 1.2.3 Global Intravenous Injection Immunoglobulin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Intravenous Injection Immunoglobulin Market Dynamics
  1. 2.1 Intravenous Injection Immunoglobulin Industry Trends
  2. 2.2 Intravenous Injection Immunoglobulin Industry Drivers
  3. 2.3 Intravenous Injection Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Intravenous Injection Immunoglobulin Industry Restraints
3 Intravenous Injection Immunoglobulin Market by Company
  1. 3.1 Global Intravenous Injection Immunoglobulin Company Revenue Ranking in 2025
  2. 3.2 Global Intravenous Injection Immunoglobulin Revenue by Company (2021-2026)
  3. 3.3 Global Intravenous Injection Immunoglobulin Sales Volume by Company (2021-2026)
  4. 3.4 Global Intravenous Injection Immunoglobulin Average Price by Company (2021-2026)
  5. 3.5 Global Intravenous Injection Immunoglobulin Company Ranking (2024-2026)
  6. 3.6 Global Intravenous Injection Immunoglobulin Company Manufacturing Base and Headquarters
  7. 3.7 Global Intravenous Injection Immunoglobulin Company Product Type and Application
  8. 3.8 Global Intravenous Injection Immunoglobulin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Intravenous Injection Immunoglobulin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Intravenous Injection Immunoglobulin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Intravenous Injection Immunoglobulin Market by Type
  1. 4.1 Intravenous Injection Immunoglobulin Type Introduction
  2. 4.1.1 5g/100ml
  3. 4.1.2 2.5g/50ml
  4. 4.1.3 1g/20ml
  5. 4.1.4 10g/200ml
  6. 4.1.5 1.25g/25ml
  7. 4.2 Global Intravenous Injection Immunoglobulin Sales Volume by Type
  8. 4.2.1 Global Intravenous Injection Immunoglobulin Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Intravenous Injection Immunoglobulin Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Intravenous Injection Immunoglobulin Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Intravenous Injection Immunoglobulin Sales Value by Type
  12. 4.3.1 Global Intravenous Injection Immunoglobulin Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Intravenous Injection Immunoglobulin Sales Value by Type (2021-2032)
  14. 4.3.3 Global Intravenous Injection Immunoglobulin Sales Value Share by Type (2021-2032)
5 Intravenous Injection Immunoglobulin Market by Application
  1. 5.1 Intravenous Injection Immunoglobulin Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Injection Immunoglobulin Sales Volume by Application
  6. 5.2.1 Global Intravenous Injection Immunoglobulin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Injection Immunoglobulin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Intravenous Injection Immunoglobulin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Intravenous Injection Immunoglobulin Sales Value by Application
  10. 5.3.1 Global Intravenous Injection Immunoglobulin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous Injection Immunoglobulin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Intravenous Injection Immunoglobulin Sales Value Share by Application (2021-2032)
6 Intravenous Injection Immunoglobulin Regional Sales and Value Analysis
  1. 6.1 Global Intravenous Injection Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Injection Immunoglobulin Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Injection Immunoglobulin Sales by Region: 2021-2026
  4. 6.2.2 Global Intravenous Injection Immunoglobulin Sales by Region (2027-2032)
  5. 6.3 Global Intravenous Injection Immunoglobulin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Intravenous Injection Immunoglobulin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Intravenous Injection Immunoglobulin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Intravenous Injection Immunoglobulin Sales Value by Region (2027-2032)
  9. 6.5 Global Intravenous Injection Immunoglobulin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Intravenous Injection Immunoglobulin Sales Value (2021-2032)
  12. 6.6.2 North America Intravenous Injection Immunoglobulin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Intravenous Injection Immunoglobulin Sales Value (2021-2032)
  15. 6.7.2 Europe Intravenous Injection Immunoglobulin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Intravenous Injection Immunoglobulin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Intravenous Injection Immunoglobulin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Intravenous Injection Immunoglobulin Sales Value (2021-2032)
  21. 6.9.2 South America Intravenous Injection Immunoglobulin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Intravenous Injection Immunoglobulin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Intravenous Injection Immunoglobulin Sales Value Share by Country, 2025 VS 2032
7 Intravenous Injection Immunoglobulin Country-level Sales and Value Analysis
  1. 7.1 Global Intravenous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intravenous Injection Immunoglobulin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Intravenous Injection Immunoglobulin Sales by Country (2021-2032)
  4. 7.3.1 Global Intravenous Injection Immunoglobulin Sales by Country (2021-2026)
  5. 7.3.2 Global Intravenous Injection Immunoglobulin Sales by Country (2027-2032)
  6. 7.4 Global Intravenous Injection Immunoglobulin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Intravenous Injection Immunoglobulin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Intravenous Injection Immunoglobulin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Intravenous Injection Immunoglobulin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Intravenous Injection Immunoglobulin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Intravenous Injection Immunoglobulin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boya-Bio
  2. 8.1.1 Boya-Bio Company Information
  3. 8.1.2 Boya-Bio Business Overview
  4. 8.1.3 Boya-Bio Intravenous Injection Immunoglobulin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boya-Bio Intravenous Injection Immunoglobulin Product Portfolio
  6. 8.1.5 Boya-Bio Recent Developments
  7. 8.2 CTBB
  8. 8.2.1 CTBB Company Information
  9. 8.2.2 CTBB Business Overview
  10. 8.2.3 CTBB Intravenous Injection Immunoglobulin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CTBB Intravenous Injection Immunoglobulin Product Portfolio
  12. 8.2.5 CTBB Recent Developments
  13. 8.3 Sinopharm
  14. 8.3.1 Sinopharm Company Information
  15. 8.3.2 Sinopharm Business Overview
  16. 8.3.3 Sinopharm Intravenous Injection Immunoglobulin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sinopharm Intravenous Injection Immunoglobulin Product Portfolio
  18. 8.3.5 Sinopharm Recent Developments
  19. 8.4 Beijing Tiantan Biological Products
  20. 8.4.1 Beijing Tiantan Biological Products Company Information
  21. 8.4.2 Beijing Tiantan Biological Products Business Overview
  22. 8.4.3 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Portfolio
  24. 8.4.5 Beijing Tiantan Biological Products Recent Developments
  25. 8.5 Guangdong Shuagnlin Bio-pharmacy
  26. 8.5.1 Guangdong Shuagnlin Bio-pharmacy Company Information
  27. 8.5.2 Guangdong Shuagnlin Bio-pharmacy Business Overview
  28. 8.5.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Portfolio
  30. 8.5.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments
  31. 8.6 Hualan Bio
  32. 8.6.1 Hualan Bio Company Information
  33. 8.6.2 Hualan Bio Business Overview
  34. 8.6.3 Hualan Bio Intravenous Injection Immunoglobulin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hualan Bio Intravenous Injection Immunoglobulin Product Portfolio
  36. 8.6.5 Hualan Bio Recent Developments
  37. 8.7 Nanyue Biopharming
  38. 8.7.1 Nanyue Biopharming Company Information
  39. 8.7.2 Nanyue Biopharming Business Overview
  40. 8.7.3 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nanyue Biopharming Intravenous Injection Immunoglobulin Product Portfolio
  42. 8.7.5 Nanyue Biopharming Recent Developments
  43. 8.8 Shanghai RAAS
  44. 8.8.1 Shanghai RAAS Company Information
  45. 8.8.2 Shanghai RAAS Business Overview
  46. 8.8.3 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai RAAS Intravenous Injection Immunoglobulin Product Portfolio
  48. 8.8.5 Shanghai RAAS Recent Developments
  49. 8.9 Weiguang Biological
  50. 8.9.1 Weiguang Biological Company Information
  51. 8.9.2 Weiguang Biological Business Overview
  52. 8.9.3 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Weiguang Biological Intravenous Injection Immunoglobulin Product Portfolio
  54. 8.9.5 Weiguang Biological Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Injection Immunoglobulin Value Chain Analysis
  2. 9.1.1 Intravenous Injection Immunoglobulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Injection Immunoglobulin Sales Mode & Process
  6. 9.2 Intravenous Injection Immunoglobulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Injection Immunoglobulin Distributors
  9. 9.2.3 Intravenous Injection Immunoglobulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst